Operating Income (Loss) in USD of BIOXYTRAN, INC from Q2 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Bioxytran, Inc quarterly/annual Operating Income (Loss) history and change rate from Q2 2010 to Q3 2025.
  • Bioxytran, Inc Operating Income (Loss) for the quarter ending 30 Sep 2025 was -$496K, a 43.3% decline year-over-year.
  • Bioxytran, Inc Operating Income (Loss) for the twelve months ending 30 Sep 2025 was -$1.72M, a 37.1% increase year-over-year.
  • Bioxytran, Inc annual Operating Income (Loss) for 2024 was -$2.22M, a 41.5% increase from 2023.
  • Bioxytran, Inc annual Operating Income (Loss) for 2023 was -$3.8M, a 56% decline from 2022.
  • Bioxytran, Inc annual Operating Income (Loss) for 2022 was -$2.44M, a 42.2% increase from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

BIOXYTRAN, INC Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$1.72M -$496K -$150K -43.3% 01 Jul 2025 30 Sep 2025 10-Q 14 Nov 2025
Q2 2025 -$1.57M -$224K +$385K +63.2% 01 Apr 2025 30 Jun 2025 10-Q 11 Aug 2025
Q1 2025 -$1.96M -$515K +$264K +33.9% 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025
Q4 2024 -$2.22M -$488K +$519K +51.5% 01 Oct 2024 31 Dec 2024 10-K 03 Apr 2025
Q3 2024 -$2.74M -$346K +$639K +64.9% 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2025
Q2 2024 -$3.38M -$609K +$448K +42.4% 01 Apr 2024 30 Jun 2024 10-Q 11 Aug 2025
Q1 2024 -$3.83M -$779K -$29K -3.86% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025
Q4 2023 -$3.8M -$1.01M +$87.6K +8.01% 01 Oct 2023 31 Dec 2023 10-K 03 Apr 2025
Q3 2023 -$3.89M -$985K -$1M -7028% 01 Jul 2023 30 Sep 2023 10-Q 29 Oct 2024
Q2 2023 -$2.89M -$1.06M -$520K -96.9% 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2024
Q1 2023 -$2.37M -$750K +$68.9K +8.41% 01 Jan 2023 31 Mar 2023 10-Q 19 Apr 2024
Q4 2022 -$2.44M -$1.09M -$158K -16.9% 01 Oct 2022 31 Dec 2022 10-K/A 13 Jan 2025
Q3 2022 -$2.28M $14.2K +$561K 01 Jul 2022 30 Sep 2022 10-Q 03 Nov 2023
Q2 2022 -$2.84M -$537K +$505K +48.5% 01 Apr 2022 30 Jun 2022 10-Q 31 Jul 2023
Q1 2022 -$3.34M -$819K +$870K +51.5% 01 Jan 2022 31 Mar 2022 10-Q 12 May 2023
Q4 2021 -$4.21M -$936K -$160K -20.6% 01 Oct 2021 31 Dec 2021 10-K 31 Mar 2023
Q3 2021 -$4.05M -$547K -$433K -378% 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022
Q2 2021 -$3.62M -$1.04M -$930K -831% 01 Apr 2021 30 Jun 2021 10-Q 15 Aug 2022
Q1 2021 -$2.69M -$1.69M -$1.42M -535% 01 Jan 2021 31 Mar 2021 10-Q 23 May 2022
Q4 2020 -$1.27M -$776K -$231K -42.4% 01 Oct 2020 31 Dec 2020 10-K 11 Apr 2022
Q3 2020 -$1.04M -$114K +$736K +86.5% 01 Jul 2020 30 Sep 2020 10-Q 17 Nov 2021
Q2 2020 -$1.77M -$112K -$5.41K -5.08% 01 Apr 2020 30 Jun 2020 10-Q 10 Aug 2021
Q1 2020 -$1.77M -$266K -$136K -105% 01 Jan 2020 31 Mar 2020 10-Q 17 May 2021
Q4 2019 -$1.63M -$545K -$378K -227% 01 Oct 2019 31 Dec 2019 10-K 09 Apr 2021
Q3 2019 -$1.25M -$850K -$803K -1689% 01 Jul 2019 30 Sep 2019 10-Q 13 Nov 2020
Q2 2019 -$450K -$106K -$106K 01 Apr 2019 30 Jun 2019 10-Q 07 Aug 2020
Q1 2019 -$344K -$130K -$129K 01 Jan 2019 31 Mar 2019 10-Q 13 May 2020
Q4 2018 -$215K -$167K -$80.2K -92.8% 01 Oct 2018 31 Dec 2018 10-K 18 Mar 2020
Q3 2018 -$135K -$47.5K -$98.4K -193% 01 Jul 2018 30 Sep 2018 10-Q 13 Nov 2019
Q2 2018 -$36.5K -$275* +$258K 01 Apr 2018 30 Jun 2018 10-Q 09 Aug 2019
Q1 2018 -$295K -$670* +$62K 01 Jan 2018 31 Mar 2018 10-Q 10 May 2019
Q4 2017 -$357K -$86.4K -$224K -163% 05 Oct 2017 31 Dec 2017 10-K 13 Mar 2019
Q3 2017 -$133K $50.8K +$263K 01 Jul 2017 30 Sep 2017 10-Q 07 Nov 2017
Q2 2017 -$396K -$258K -$115K -80.3% 01 Apr 2017 30 Jun 2017 10-Q 31 Jul 2018
Q1 2017 -$281K -$62.6K +$390K +86.2% 01 Jan 2017 31 Mar 2017 10-Q 15 May 2018
Q4 2016 -$671K $137K +$250K 01 Oct 2016 31 Dec 2016 10-K 02 Apr 2018
Q3 2016 -$921K -$212K -$184K -653% 01 Jul 2016 30 Sep 2016 10-Q 07 Nov 2017
Q2 2016 -$738K -$143K +$1.77M +92.5% 01 Apr 2016 30 Jun 2016 10-Q 14 Aug 2017
Q1 2016 -$2.51M -$453K -$416K -1118% 01 Jan 2016 31 Mar 2016 10-Q 15 May 2017
Q4 2015 -$2.09M -$113K +$63.1K +35.8% 01 Oct 2015 31 Dec 2015 10-K 31 Mar 2017
Q3 2015 -$2.16M -$28.2K +$1.09M +97.5% 01 Jul 2015 30 Sep 2015 10-Q 09 Dec 2016
Q2 2015 -$3.24M -$1.91M -$1.86M -3308% 01 Apr 2015 30 Jun 2015 10-Q 20 Sep 2016
Q1 2015 -$1.38M -$37.2K -$103K -157% 01 Jan 2015 31 Mar 2015 10-Q 20 Sep 2016
Q4 2014 -$1.28M -$176K -$83.1K -89.5% 01 Oct 2014 31 Dec 2014 10-K 20 Sep 2016
Q3 2014 -$1.2M -$1.11M -$839K -305% 01 Jul 2014 30 Sep 2014 10-Q 12 Nov 2015
Q2 2014 -$358K -$56.2K +$575K +91.1% 01 Apr 2014 30 Jun 2014 10-Q 19 Aug 2015
Q1 2014 -$934K $65.8K +$1.04M 01 Jan 2014 31 Mar 2014 10-Q 14 May 2014
Q4 2013 -$1.97M -$92.9K +$569K +86% 01 Oct 2013 31 Dec 2013 10-K 10 Apr 2015
Q3 2013 -$2.54M -$275K +$211K +43.4% 01 Jul 2013 30 Sep 2013 10-Q 13 Nov 2014
Q2 2013 -$2.75M -$632K +$33.4K +5.02% 31 Mar 2013 30 Jun 2013 10-Q 12 Aug 2014
Q1 2013 -$2.79M -$973K -$497K -104% 01 Jan 2013 31 Mar 2013 10-Q 14 May 2014
Q4 2012 -$2.29M -$662K +$1.9M +74.2% 01 Oct 2012 31 Dec 2012 10-K 14 Apr 2014
Q3 2012 -$4.19M -$486K -$138K -39.7% 01 Jul 2012 30 Sep 2012 10-Q 18 Nov 2013
Q2 2012 -$4.05M -$665K -$533K -403% 31 Mar 2012 30 Jun 2012 10-Q 15 Aug 2013
Q1 2012 -$3.52M -$476K +$910K +65.6% 01 Jan 2012 31 Mar 2012 10-Q 15 May 2013
Q4 2011 -$4.43M -$2.56M 01 Oct 2011 31 Dec 2011 10-K 15 Apr 2013
Q3 2011 -$348K -$278K -399% 01 Jul 2011 30 Sep 2011 10-Q/A 31 Dec 2012
Q2 2011 -$132K -$11.7K -9.73% 01 Apr 2011 30 Jun 2011 10-Q/A 22 Jan 2013
Q1 2011 -$1.39M 01 Jan 2011 31 Mar 2011 10-Q/A 22 Jan 2013
Q3 2010 -$69.8K 01 Jul 2010 30 Sep 2010 10-Q/A 31 Dec 2012
Q2 2010 -$121K 01 Apr 2010 30 Jun 2010 10-Q/A 31 Dec 2012

BIOXYTRAN, INC Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$2.22M +$1.58M +41.5% 01 Jan 2024 31 Dec 2024 10-K 03 Apr 2025
2023 -$3.8M -$1.36M -56% 01 Jan 2023 31 Dec 2023 10-K 03 Apr 2025
2022 -$2.44M +$1.78M +42.2% 01 Jan 2022 31 Dec 2022 10-K/A 13 Jan 2025
2021 -$4.21M -$2.95M -232% 01 Jan 2021 31 Dec 2021 10-K 31 Mar 2023
2020 -$1.27M +$363K +22.2% 01 Jan 2020 31 Dec 2020 10-K 11 Apr 2022
2019 -$1.63M -$1.42M -658% 01 Jan 2019 31 Dec 2019 10-K 09 Apr 2021
2018 -$215K +$95.5K +30.7% 01 Jan 2018 31 Dec 2018 10-K 18 Mar 2020
2017 -$311K +$361K +53.7% 01 Jan 2017 31 Dec 2017 10-K 02 Apr 2018
2016 -$671K +$1.42M +67.9% 01 Jan 2016 31 Dec 2016 10-K 02 Apr 2018
2015 -$2.09M -$812K -63.4% 01 Jan 2015 31 Dec 2015 10-K 31 Mar 2017
2014 -$1.28M +$692K +35.1% 01 Jan 2014 31 Dec 2014 10-K 20 Sep 2016
2013 -$1.97M +$317K +13.9% 01 Jan 2013 31 Dec 2013 10-K 10 Apr 2015
2012 -$2.29M +$2.14M +48.3% 01 Jan 2012 31 Dec 2012 10-K 14 Apr 2014
2011 -$4.43M -$4.1M -1246% 01 Jan 2011 31 Dec 2011 10-K 15 Apr 2013
2010 -$329K 01 Jan 2010 31 Dec 2010 10-K/A 31 Dec 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.